Caroline von Spee-Mayer

Author

University Medical Center Freiburg ORCID

Also Known As

C von Spee, C von Spee-Mayer, C. Von Spee-Mayer, C. von Spee, C. von Spee-Mayer, Caroline Von Spee-Mayer, Caroline von Spee, Caroline von Spee-Mayer, Spee-Mayer, Caroline

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

University Medical Center Freiburg University of Freiburg Charité - Universitätsmedizin Berlin University of Lübeck German Rheumatism Research Centre

About

Caroline von Spee-Mayer is an author at University Medical Center Freiburg specializing in medicine, autoimmune disease, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	193
2	Immunology	3	3	127
3	Allergy	1	1	34
4	Epidemiology	1	1	43
5	Medical Laboratory Science	1	1	43

Caroline von Spee-Mayer

Publications

Citations

H-Index

Page 1

	Year	Citations
Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus Caroline von Spee-Mayer, Elise Siegert, Dimas Abdirama, Annals of the Rheumatic Diseases	2015	325
Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients Omri Snir, Mona Widhe, Monika Hermansson, Arthritis & Rheumatism	2009	202
Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles Omri Snir, Mona Widhe, Caroline von Spee-Mayer, Annals of the Rheumatic Diseases	2008	191
Low-dose interleukin-2 therapy in refractory systemic lupus erythematosus: an investigator-initiated, single-centre phase 1 and 2a clinical trial Jens Y. Humrich, Caroline von Spee-Mayer, Elise Siegert, The Lancet Rheumatology RheumatologyAutoimmune DiseaseSystemic Lupus Erythematosus TreatmentLupusSystemic Treatment	2019	74
CD4+Foxp3+ regulatory T cells prolong drug-induced disease remission in (NZBxNZW) F1 lupus mice Olivia Weigert, Caroline von Spee-Mayer, Reinmar Undeutsch, Arthritis Research & Therapy	2013	56
Evaluating laboratory criteria for combined immunodeficiency in adult patients diagnosed with common variable immunodeficiency Caroline von Spee-Mayer, Verena Koemm, Claudia Wehr, Clinical Immunology Primary ImmunodeficiencyLaboratory CriteriaSexual HealthTreatment And PreventionMedicine	2019	43
Nuclear antigen–reactive CD4+ T cells expand in active systemic lupus erythematosus, produce effector cytokines, and invade the kidneys Dimas Abdirama, Sebastian Tesch, Anna‐Sophie Grießbach, Kidney International	2020	40
IL-2 Therapy Diminishes Renal Inflammation and the Activity of Kidney-Infiltrating CD4+ T Cells in Murine Lupus Nephritis Angelika Rose, Caroline von Spee-Mayer, Lutz Kloke, Cells ImmunodeficienciesT-regulatory CellImmunologyRenal InflammationImmune Regulation	2019	34
Interferon-Driven Immune Dysregulation in Common Variable Immunodeficiency–Associated Villous Atrophy and Norovirus Infection Valentina Strohmeier, Geoffroy Andrieux, Susanne Unger, Journal of Clinical Immunology	2022	27
Abatacept Use Is Associated with Steroid Dose Reduction and Improvement in Fatigue and CD4-Dysregulation in CVID Patients with Interstitial Lung Disease Caroline von Spee-Mayer, Constanze Echternach, Prerana Agarwal, The Journal of Allergy and Clinical Immunology In Practice Translational MedicineAbatacept UseAutoimmune DiseaseAdvanced Lung DiseaseMedicine	2020	23

Page 1